FACULTY
Retina Specialist Simulation Track
Susan Bressler, MD
The Julia G. Levy, PhD Professor of Ophthalmology
Department of Ophthalmology
Johns Hopkins University School of Medicine
Baltimore, MD
Ophthalmology Simulation Track
Victoria Epstein, DO
Ophthalmologist and Surgeon
Neuro-ophthalmology and Medical Retina
Albany Eye Associates
Albany, NY
Optometry Simulation Track
Julie Rodman OD, MSc, FAAO
Professor of Optometry
Nova Southeastern University
Fort Lauderdale, FL
PROGRAM OVERVIEW
This Immersive Simulation Experience in diabetic retinopathy (DR), neovascular age-related macular degeneration (nAMD) and retinal vein occlusion (RVO) allows learners to engage in clinical decision-making to individualize treatment with anti-vascular endothelial growth factor (anti-VEGF) therapies. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care, including identifying eyes that may benefit from anti-VEGF treatment, incorporating assessment of efficacy and safety data into treatment decisions, and strategizing changes in treatment approach to achieve optimal outcomes.
TARGET AUDIENCE
This activity is designed to meet the educational needs of retina specialists, ophthalmologists, optometrists, and other healthcare providers who manage patients with diabetic retinopathy, age-related macular degeneration, and/or retinal vein occlusion.
LEARNING OBJECTIVES
- Individualize patient treatment plans by selecting anti-VEGF agents for management of DR, nAMD, and RVO based on safety, efficacy, response, durability and patient factors.
- Evaluate the safety profiles of approved anti-VEGF agents for DR, nAMD, and RVO
- Improve evaluation and incorporation of safety data from clinical trials into treatment decisions
- Identify patients with DR, nAMD, or RVO who could benefit from the adjustment of their current anti-VEGF regimens
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Ophthalmology Simulation Track
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of .50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded .50 contact hour of continuing nursing education of RNs and APNs.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses who are involved in the care of patients with or at risk for DR, nAMD, and RVO.
CNE Credits: .50 ANCC Contact Hour.
Retina Specialist Simulation Track
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of .50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded .50 contact hour of continuing nursing education of RNs and APNs.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses who are involved in the care of patients with or at risk for DR, nAMD, and RVO.
CNE Credits: .50 ANCC Contact Hour.
Optometry Simulation Track
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of .50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded .50 contact hour of continuing nursing education of RNs and APNs.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses who are involved in the care of patients with or at risk for DR, nAMD, and RVO.
CNE Credits: .50 ANCC Contact Hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Susan Bressler, MD, discloses that she has conducted contracted research for Johns Hopkins University School of Medicine, and has served as Chair for the data and safety monitoring committee for Amgen.
Victoria Epstein, MD, has nothing to disclose.
Julie Rodman OD, MSc, FAAO, has nothing to disclose.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RNM
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
- Nicole Longo, DO, FACOI, Medical Director for Med Learning Group, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
- Jessica Feygin, Program Coordinator of Med Learning Group, has nothing to disclose.
- Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
- Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CE credit for this enduring activity. To receive CME/CE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Submit the evaluation form to Med Learning Group.
You will receive your certificate upon completion as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: November 18, 2022
EXPIRATION DATE: November 18, 2023
Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
